Similar to B7‐H1, the clinical significance of B7‐H3 in tumor therapy has been well documented, as elevated expression of B7‐H3 in various cancers is correlated with poor prognosis [2, 3, 4]. This evidence concerns the gene CD276 and neoplasm.